STOCK TITAN

Perrigo to Attend Jefferies Consumer Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Perrigo (NYSE: PRGO) announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled for one-on-one investor meetings at the Jefferies Miami Consumer Conference on Tuesday, November 18, 2025.

The release describes Perrigo as a pure-play consumer health company with leading OTC brands and notes investor contacts and a forward-looking statements caution directing readers to the company's SEC filings for risks and financial information.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 51 Alerts

-1.66% News Effect
-16.3% Trough in 9 hr 17 min
-$47M Valuation Impact
$2.78B Market Cap
5.7x Rel. Volume

On the day this news was published, PRGO declined 1.66%, reflecting a mild negative market reaction. Argus tracked a trough of -16.3% from its starting point during tracking. Our momentum scanner triggered 51 alerts that day, indicating high trading interest and price volatility. This price movement removed approximately $47M from the company's valuation, bringing the market cap to $2.78B at that time. Trading volume was exceptionally heavy at 5.7x the daily average, suggesting significant selling pressure.

Data tracked by StockTitan Argus on the day of publication.

DUBLIN, Nov. 4, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer health products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to participate in one-on-one investor meetings at the Jefferies Miami Consumer Conference on Tuesday, November 18th, 2025.

About Perrigo   

Perrigo Company plc is a leading pure-play consumer health company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers.

Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®.

For more information, visit www.perrigo.com.

Forward-Looking Statements  

This press release includes, and the matters discussed at the Jefferies Miami Consumer Conference will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at https://investor.perrigo.com/sec-filings, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2024.

Perrigo Contact

Bradley Joseph, Vice President, Global Investor Relations, (269) 686-3373, E-mail: bradley.joseph@perrigo.com

Nicholas Gallagher, Associate Director, Global Investor Relations, (269) 686-3238, E-mail: nicholas.gallagher@perrigo.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/perrigo-to-attend-jefferies-consumer-conference-302604074.html

SOURCE Perrigo Company plc

FAQ

When will Perrigo (PRGO) management attend the Jefferies Miami Consumer Conference in 2025?

Perrigo management is scheduled for one-on-one investor meetings on Tuesday, November 18, 2025.

Who will represent Perrigo (PRGO) at the Jefferies Miami Consumer Conference?

President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to participate.

How can investors request a meeting or more information about Perrigo (PRGO) at the conference?

Investors should contact investor relations: Bradley Joseph at (269) 686-3373 or bradley.joseph@perrigo.com, or Nicholas Gallagher at (269) 686-3238 or nicholas.gallagher@perrigo.com.

Will Perrigo (PRGO) release financial results or guidance at the Jefferies Miami Consumer Conference?

The announcement only notes one-on-one investor meetings and does not disclose any planned earnings or guidance releases.

Where can investors find Perrigo (PRGO) regulatory disclosures referenced in the conference notice?

Regulatory filings and risk information are available at Perrigo's SEC filings page: https://investor.perrigo.com/sec-filings.

What is Perrigo's business focus as described in the conference announcement for PRGO?

Perrigo is described as a pure-play consumer health company focused on OTC self-care and store-brand private label offerings alongside leading brands.
Perrigo Co Plc

NYSE:PRGO

PRGO Rankings

PRGO Latest News

PRGO Latest SEC Filings

PRGO Stock Data

1.89B
137.01M
0.41%
105.88%
5.38%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
Ireland
DUBLIN 2